甲状旁腺功能亢进症的遗传学，包括甲状旁腺癌。
Genetics of Hyperparathyroidism, Including Parathyroid Cancer.
机构信息
Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 8C-101, 10 Center Drive, MSC 1752, Bethesda, MD 20892, USA.
出版信息
Endocrinol Metab Clin North Am. 2017 Jun;46(2):405-418. doi: 10.1016/j.ecl.2017.01.006. Epub 2017 Feb 23.
Abstract
Primary hyperparathyroidism (HPT) is a metabolic disease caused by the excessive secretion of parathyroid hormone from 1 or more neoplastic parathyroid glands. HPT is largely sporadic, but it can be associated with a familial syndrome. The study of such families led to the discovery of tumor suppressor genes whose loss of function is now recognized to underlie the development of many sporadic parathyroid tumors. Heritable and acquired oncogenes causing parathyroid neoplasia are also known. Studies of somatic changes in parathyroid tumor DNA and investigation of kindreds with unexplained familial HPT promise to unmask more genes relevant to parathyroid neoplasia.
摘要
原发性甲状旁腺功能亢进症（HPT）是一种由甲状旁腺激素从 1 个或多个肿瘤性甲状旁腺过度分泌引起的代谢性疾病。HPT 主要是散发性的，但它可能与家族综合征有关。对这些家族的研究导致了肿瘤抑制基因的发现，其功能丧失现在被认为是许多散发性甲状旁腺肿瘤发展的基础。导致甲状旁腺肿瘤发生的遗传性和获得性癌基因也已被发现。对甲状旁腺肿瘤 DNA 的体细胞变化的研究以及对原因不明的家族性 HPT 的家族调查有望揭示更多与甲状旁腺肿瘤发生相关的基因。
相似文献
1
Genetics of Hyperparathyroidism, Including Parathyroid Cancer.甲状旁腺功能亢进症的遗传学，包括甲状旁腺癌。
Endocrinol Metab Clin North Am. 2017 Jun;46(2):405-418. doi: 10.1016/j.ecl.2017.01.006. Epub 2017 Feb 23.
2
Clinical and molecular genetics of parathyroid neoplasms.甲状旁腺肿瘤的临床和分子遗传学。
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):491-502. doi: 10.1016/j.beem.2010.01.003.
3
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.甲状旁腺癌的综合征型和非综合征型的分子遗传学。
Hum Mutat. 2017 Dec;38(12):1621-1648. doi: 10.1002/humu.23337. Epub 2017 Sep 25.
4
Familial Hyperparathyroidism.家族性甲状旁腺功能亢进症。
Front Endocrinol (Lausanne). 2021 Feb 25;12:623667. doi: 10.3389/fendo.2021.623667. eCollection 2021.
5
Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.对两个患有家族性孤立性甲状旁腺功能亢进症的意大利家系进行MEN1基因和HPRT2基因座的遗传分析。
Clin Endocrinol (Oxf). 2002 Apr;56(4):457-64. doi: 10.1046/j.1365-2265.2002.01502.x.
6
Clinical and Molecular Genetics of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进的临床与分子遗传学
Horm Metab Res. 2020 Aug;52(8):578-587. doi: 10.1055/a-1132-6223. Epub 2020 Mar 30.
7
Genetic defects associated with familial and sporadic hyperparathyroidism.与家族性和散发性甲状旁腺功能亢进相关的遗传缺陷。
Front Horm Res. 2013;41:149-65. doi: 10.1159/000345675. Epub 2013 Mar 19.
8
Familial parathyroid tumours-comparison of clinical profiles between syndromes.家族性甲状旁腺肿瘤——综合征间临床特征的比较。
J Endocrinol Invest. 2023 Sep;46(9):1799-1806. doi: 10.1007/s40618-023-02032-4. Epub 2023 Feb 13.
9
Molecular pathogenesis of primary hyperparathyroidism.原发性甲状旁腺功能亢进症的分子发病机制。
J Bone Miner Res. 2002 Nov;17 Suppl 2:N30-6.
10
Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.由单一腺瘤引起的家族性孤立性甲状旁腺功能亢进症：一种不同于多发性内分泌肿瘤的独特实体。
Endocr J. 1998 Oct;45(5):637-46. doi: 10.1507/endocrj.45.637.
引用本文的文献
1
Genetics of Gallstones.胆结石的遗传学
Genes (Basel). 2025 Feb 22;16(3):256. doi: 10.3390/genes16030256.
2
Craniofacial disorders and dysplasias: Molecular, clinical, and management perspectives.颅面疾病与发育异常：分子、临床及管理视角
Bone Rep. 2024 Mar 1;20:101747. doi: 10.1016/j.bonr.2024.101747. eCollection 2024 Mar.
3
The Role of Demographic and Clinical Factors in Germline Mutation Testing for Patients with Primary Hyperparathyroidism.人口统计学和临床因素在原发性甲状旁腺功能亢进症患者种系突变检测中的作用。
Ann Surg Oncol. 2024 Jun;31(6):3964-3971. doi: 10.1245/s10434-024-15104-3. Epub 2024 Mar 8.
4
[Special features of the diagnostics and treatment of hereditary primary hyperparathyroidism].[遗传性原发性甲状旁腺功能亢进症的诊断与治疗特点]
Chirurgie (Heidelb). 2023 Jul;94(7):586-594. doi: 10.1007/s00104-023-01897-8. Epub 2023 Jun 8.
5
Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.CDC73 基因罕见重复与非典型甲状旁腺功能亢进-颌骨肿瘤综合征：病例报告及文献复习。
Mol Genet Genomic Med. 2023 May;11(5):e2133. doi: 10.1002/mgg3.2133. Epub 2023 Jan 14.
6
Mathematical model for preoperative differential diagnosis for the parathyroid neoplasms.甲状旁腺肿瘤术前鉴别诊断的数学模型
J Pathol Inform. 2022 Aug 27;13:100134. doi: 10.1016/j.jpi.2022.100134. eCollection 2022.
7
Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT.鉴定与原发性甲状旁腺功能亢进症（PHPT）相关的 4 个新基因座和 PHPT 的多基因风险评分。
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3302-3308. doi: 10.1210/clinem/dgac527.
8
Parathyroid carcinoma presenting with ventricular bigeminy in pregnancy.甲状旁腺癌伴妊娠时心室二联律。
BMJ Case Rep. 2022 Feb 8;15(2):e247069. doi: 10.1136/bcr-2021-247069.
9
RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.RET 通过激活 CDK5 和 STAT3 调控人甲状腺髓样癌细胞增殖。
Biomolecules. 2021 Jun 9;11(6):860. doi: 10.3390/biom11060860.
10
Hyperparathyroidism-Jaw Tumor Syndrome.甲状旁腺功能亢进-颌骨肿瘤综合征
Case Rep Oncol. 2021 Feb 18;14(1):29-33. doi: 10.1159/000510002. eCollection 2021 Jan-Apr.
本文引用的文献
1
Primary hyperparathyroidism.原发性甲状旁腺功能亢进症。
Nat Rev Dis Primers. 2016 May 19;2:16033. doi: 10.1038/nrdp.2016.33.
2
Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.1型和3型家族性低钙血症性高钙血症与原发性甲状旁腺功能亢进症：异同
J Clin Endocrinol Metab. 2016 May;101(5):2185-95. doi: 10.1210/jc.2015-3442. Epub 2016 Mar 10.
3
EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.EZH2和ZFX癌基因在甲状旁腺肿瘤恶性行为中的作用
Endocrine. 2016 Oct;54(1):55-59. doi: 10.1007/s12020-016-0892-y. Epub 2016 Feb 15.
4
A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).G蛋白亚基α11功能丧失性突变Thr54Met导致2型家族性低钙血症性高钙血症（FHH2）。
J Bone Miner Res. 2016 Jun;31(6):1200-6. doi: 10.1002/jbmr.2778. Epub 2016 Feb 6.
5
Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.遗传性甲状腺髓样癌的基因型-表型相关性
Recent Results Cancer Res. 2015;204:139-56. doi: 10.1007/978-3-319-22542-5_6.
6
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects.导致3型家族性低钙血症高钙血症（FHH3）的衔接蛋白2西格玛亚基突变表现出基因型-表型相关性、密码子偏好和显性负效应。
Hum Mol Genet. 2015 Sep 15;24(18):5079-92. doi: 10.1093/hmg/ddv226. Epub 2015 Jun 16.
7
Polyclonality of Parathyroid Tumors in Neonatal Severe Hyperparathyroidism.新生儿重症甲状旁腺功能亢进症中甲状旁腺肿瘤的多克隆性
J Bone Miner Res. 2015 Oct;30(10):1797-802. doi: 10.1002/jbmr.2516. Epub 2015 May 14.
8
Recurrent ZFX mutations in human sporadic parathyroid adenomas.人类散发性甲状旁腺腺瘤中ZFX基因的复发性突变。
Oncoscience. 2014 May 6;1(5):360-6. doi: 10.18632/oncoscience.116. eCollection 2014.
9
New role for ZFX in oncogenesis.ZFX在肿瘤发生中的新作用。
Cell Cycle. 2014;13(22):3465-6. doi: 10.4161/15384101.2014.980693.
10
Hyperparathyroidism-jaw tumor syndrome: Results of operative management.甲状旁腺功能亢进-颌骨肿瘤综合征：手术治疗结果
Surgery. 2014 Dec;156(6):1315-24; discussion 1324-5. doi: 10.1016/j.surg.2014.08.004. Epub 2014 Oct 16.
Zotero 插件